Farmaceutica R (RMAH) - Total Liabilities
Based on the latest financial reports, Farmaceutica R (RMAH) has total liabilities worth RON271.82 Million RON (≈ $62.41 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See RMAH defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Farmaceutica R - Total Liabilities Trend (2020–2025)
This chart illustrates how Farmaceutica R's total liabilities have evolved over time, based on quarterly financial data. See Farmaceutica R (RMAH) balance sheet quality index to measure how much of total assets are equity-financed.
Farmaceutica R Competitors by Total Liabilities
The table below lists competitors of Farmaceutica R ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Diamyd Medical AB (publ)
ST:DMYD-B
|
Sweden | Skr147.23 Million |
|
Atlantis Yatirim Holding AS
IS:ATSYH
|
Turkey | TL23.24 Million |
|
Wang-Zheng Bhd
KLSE:7203
|
Malaysia | RM71.43 Million |
|
Dyadic International Inc
NASDAQ:DYAI
|
USA | $9.07 Million |
|
Coast Copper Corp
V:COCO
|
Canada | CA$202.06K |
|
Pantera Silver Corp
V:PNTR
|
Canada | CA$150.53K |
|
Magnum Mining and Exploration Ltd
AU:MGU
|
Australia | AU$1.11 Million |
|
N.C. Housing Public Company Limited
BK:NCH
|
Thailand | ฿1.72 Billion |
Liability Composition Analysis (2020–2025)
This chart breaks down Farmaceutica R's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Farmaceutica R balance sheet assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.79 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Farmaceutica R's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Farmaceutica R (2020–2025)
The table below shows the annual total liabilities of Farmaceutica R from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | RON303.58 Million ≈ $69.71 Million |
+0.82% |
| 2024-09-30 | RON301.09 Million ≈ $69.14 Million |
+22.94% |
| 2023-09-30 | RON244.90 Million ≈ $56.23 Million |
+12.46% |
| 2022-09-30 | RON217.77 Million ≈ $50.00 Million |
+19.10% |
| 2021-09-30 | RON182.85 Million ≈ $41.99 Million |
+11.07% |
| 2020-09-30 | RON164.63 Million ≈ $37.80 Million |
-- |
About Farmaceutica R
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics and warehousing, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 199… Read more